AI stocks
搜索文档
Jim Cramer on DraftKings: “It’s in the Wilderness”
Yahoo Finance· 2026-01-31 21:48
DraftKings Inc. (NASDAQ:DKNG) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages. When a caller inquired about the stock, Cramer remarked: Okay, I like DraftKings, but I’ve decided, you know what, without Florida, without Texas, without California gambling, it’s just going to be like, I don’t know, it’s in the wilderness. I don’t know. I want it out of the wilderness. It’s not an expensive stock. Or maybe we need a lot of consolidation. That could do it. A tech ...
Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma
Yahoo Finance· 2026-01-31 21:31
公司评级与目标价 - 花旗在1月27日将艾伯维的目标价从235美元小幅下调至230美元 同时维持中性评级 [2] - 此次调整是花旗对生物制药行业进行更广泛的第四季度评估的一部分 [2] 行业前景与风险 - 花旗认为 整个生物制药行业的盈利预期看起来可控 实际业绩可能好于担忧 且政策相关风险降低可能在2026年为该行业创造更有利的背景 [2] 产品研发进展 - 1月16日 艾伯维及其合作伙伴Genmab宣布 其血癌药物epcoritamab在一项后期研究中未能显示出明确的生存获益 [3] - 该试验入组了483名复发或难治性弥漫性大B细胞淋巴瘤患者 这些患者此前至少接受过一次治疗 且不适合接受强化化疗后进行干细胞移植 [3] - 在分析时 使用该药物的患者寿命没有统计学意义上的显著延长 [4] - 研究也显示出一些积极信号:更多患者的癌症变得检测不到 缓解持续时间更长 且需要下一次治疗的时间有所改善 [4] - 艾伯维和Genmab计划与监管机构审查数据 并在即将召开的医学会议上分享更多结果 [4] - Epcoritamab已在多个国家获批用于其他淋巴瘤适应症 在美国和日本以Epkinly销售 在欧盟以Tepkinly销售 [5] 公司背景 - 艾伯维是一家全球性生物制药公司 专注于新药的发现、开发和上市 [5]
Roth Capital is Bullish on GoldMining Inc. (GLDG)
Yahoo Finance· 2026-01-31 21:14
GoldMining Inc. (NYSE:GLDG) is among the 11 Best Gold Stocks to Buy for 2026. Roth Capital is Bullish on GoldMining Inc. (GLDG) On January 7, 2026, TheFly reported that Roth Capital reaffirmed its Buy recommendation. It lifted GoldMining Inc. (NYSE:GLDG)’s price objective to $2.80 from $2.60. The increase is a result of further drilling at the Sao Jorge project, which the company claims has potential for resource growth, as well as a better valuation of the company’s interests. GoldMining Inc. (NYSE:GL ...
Vista Gold Corp. (VGZ) Establishes a Goal to Begin Thorough Engineering and Design at Mt. Todd
Yahoo Finance· 2026-01-31 21:13
Vista Gold Corp. (NYSE:VGZ) is among the 11 Best Gold Stocks to Buy for 2026. Vista Gold Corp. (VGZ) Establishes a Goal to Begin Thorough Engineering and Design at Mt. Todd Vista Gold Corp. (NYSE:VGZ) stated that it plans to start thorough engineering and design at its Mt Todd gold project by early 2027, based on a January 13, 2026, report by TheFly. The Mt Todd Feasibility Study, completed in July 2025, proposed a smaller initial project by targeting higher-grade ore, lowering initial capital expenditur ...
New Found Gold Corp. (NFGC) Completes Key Milestone at Queensway Gold Project by Entering into Phase 1 EPCM Contract
Yahoo Finance· 2026-01-31 21:13
New Found Gold Corp. (NYSE:NFGC) is among the 11 Best Gold Stocks to Buy for 2026. New Found Gold Corp. (NFGC) Completes Key Milestone at Queensway Gold Project by Entering into Phase 1 EPCM Contract On January 26, 2026, New Found Gold Corp. (NYSE:NFGC) entered into a Phase 1 EPCM contract with WSP Canada Inc. for site planning and detailed engineering of an offsite milling plant, advancing its 100%-owned Queensway Gold Project in Newfoundland and Labrador. The corporation intends to grow and modernize i ...
Caledonia Mining Corporation Plc (CMCL) Raises $150 Million for Zimbabwe’s Gold Mine in a Rare International Capital Raise
Yahoo Finance· 2026-01-31 21:12
Caledonia Mining Corporation Plc (NYSE:CMCL) is among the 11 Best Gold Stocks to Buy for 2026. Caledonia Mining Corporation Plc (CMCL) Raises $150 Million for Zimbabwe's Gold Mine in a Rare International Capital Raise Caledonia Mining Corporation Plc (NYSE:CMCL) reportedly obtained $150 million through a seven-year convertible bond sale to finance the construction of its Bilboes project, which is anticipated to grow into Zimbabwe’s largest gold mine, based on a January 21, 2026, Reuters story. After yea ...
Seabridge Gold Inc. (SA) Released a 2025 Year-End Report
Yahoo Finance· 2026-01-31 21:12
Seabridge Gold Inc. (NYSE:SA) is among the 11 Best Gold Stocks to Buy for 2026. Seabridge Gold Inc. (SA) Released a 2025 Year-End Report Seabridge Gold Inc. (NYSE:SA) released a 2025 year-end report on operations, exploration, and corporate initiatives on December 18, 2025. The company finished advanced power infrastructure and 8,500 meters of geotechnical drilling over 117 holes at KSM, setting the project up for a feasibility assessment. Seabridge anticipates improvements in 2026 and has progressed col ...
Osisko Development Corp. (ODV) Announces $125M Bought Deal Offering
Yahoo Finance· 2026-01-31 21:12
Osisko Development Corp. (NYSE:ODV) is among the 11 Best Gold Stocks to Buy for 2026. Osisko Development Corp. (ODV) Announces $125M Bought Deal Offering On January 27, 2026, TheFly reported that Osisko Development Corp. (NYSE:ODV) announced a $125 million bought deal financing on behalf of a syndicate. National Bank Capital Markets, RBC Capital Markets, and Cantor are serving as co-lead underwriters and co-bookrunners. The underwriters decided to spend $125 million in gross proceeds for 35.31 million co ...
High-Grade Silver and Gold Intercepts Boost Confidence in Avino Silver & Gold Mines Ltd. (ASM)’s Growth Plan
Yahoo Finance· 2026-01-31 20:59
We recently compiled a list of the 9 High Growth Small Cap Stocks That Are Profitable. Avino Silver & Gold Mines Ltd. stands fourth on our list of high growth stocks. TheFly reported on January 23 that H.C. Wainwright raised its price target for ASM to $12.50 from $7.40 and maintained a Buy rating. The increase followed the company’s announcement of its 2025 production results, with the higher target supported by updated price assumptions and a one-year forward adjustment to the valuation. High-Grade Sil ...
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance
Yahoo Finance· 2026-01-31 20:57
We recently compiled a list of the 9 High Growth Small Cap Stocks That Are Profitable. CorMedix Inc. tops our list for being one of the high growth stocks. TheFly reported on January 23 that H.C. Wainwright lowered the price target on CRMD to $13 from $18 while keeping a Buy rating. The adjustment reflects updated guidance for 2026–2027 related to DefenCath. The firm noted that CRMD has now entered a phase where clinical results will play a larger role than commercial performance in shaping the company’s ...